Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.59 - $1.04 $118 - $208
-200 Reduced 0.13%
156,630 $92,000
Q1 2024

May 14, 2024

BUY
$0.61 - $0.83 $27,960 - $38,044
45,837 Added 41.3%
156,830 $111,000
Q3 2023

Nov 13, 2023

BUY
$0.58 - $0.91 $18,698 - $29,337
32,239 Added 40.94%
110,993 $68,000
Q1 2023

May 15, 2023

SELL
$0.72 - $1.03 $968 - $1,385
-1,345 Reduced 1.68%
78,754 $58,000
Q4 2022

Feb 13, 2023

SELL
$0.73 - $14.6 $590 - $11,811
-809 Reduced 1.0%
80,099 $64,000
Q3 2022

Nov 14, 2022

BUY
$1.27 - $15.0 $28,421 - $335,685
22,379 Added 38.24%
80,908 $108,000
Q2 2022

Aug 12, 2022

SELL
$1.33 - $2.31 $141,339 - $245,483
-106,270 Reduced 64.48%
58,529 $95,000
Q1 2022

May 13, 2022

SELL
$1.26 - $2.52 $10,276 - $20,553
-8,156 Reduced 4.72%
164,799 $376,000
Q4 2021

Feb 08, 2022

SELL
$2.33 - $5.94 $5,880 - $14,992
-2,524 Reduced 1.44%
172,955 $403,000
Q3 2021

Nov 15, 2021

SELL
$5.89 - $9.35 $251,237 - $398,824
-42,655 Reduced 19.55%
175,479 $1.03 Million
Q2 2021

Aug 13, 2021

BUY
$9.16 - $19.51 $490,902 - $1.05 Million
53,592 Added 32.57%
218,134 $2 Million
Q1 2021

May 12, 2021

BUY
$10.64 - $14.7 $157,599 - $217,736
14,812 Added 9.89%
164,542 $2.21 Million
Q4 2020

Feb 11, 2021

BUY
$9.32 - $13.63 $67,765 - $99,103
7,271 Added 5.1%
149,730 $1.66 Million
Q3 2020

Nov 16, 2020

BUY
$8.59 - $11.89 $12,283 - $17,002
1,430 Added 1.01%
142,459 $1.35 Million
Q2 2020

Aug 14, 2020

BUY
$7.23 - $12.1 $169,138 - $283,067
23,394 Added 19.89%
141,029 $1.64 Million
Q1 2020

May 14, 2020

BUY
$5.9 - $13.8 $184,581 - $431,733
31,285 Added 36.23%
117,635 $970,000
Q4 2019

Feb 14, 2020

BUY
$6.51 - $12.23 $265,594 - $498,959
40,798 Added 89.56%
86,350 $1.06 Million
Q3 2019

Nov 13, 2019

BUY
$6.45 - $8.44 $225,169 - $294,640
34,910 Added 328.04%
45,552 $342,000
Q2 2019

Aug 13, 2019

BUY
$6.16 - $14.15 $65,554 - $150,584
10,642 New
10,642 $72,000

Others Institutions Holding HOOK

About HOOKIPA Pharma Inc.


  • Ticker HOOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,654,500
  • Market Cap $155M
  • Description
  • HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...
More about HOOK
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.